Journal article icon

Journal article

A recurrent mosaic mutation of SMO, encoding the hedgehog signal transducer Smoothened, is the major cause of Curry-Jones syndrome

Abstract:
Curry-Jones syndrome (CJS) is a multisystem disorder characterized by patchy skin lesions, polysyndactyly, diverse cerebral malformations, unicoronal craniosynostosis, iris colobomas, microphthalmia, and intestinal malrotation with myofibromas or hamartomas. Cerebellar medulloblastoma has been described in a single affected individual; in another, biopsy of skin lesions showed features of trichoblastoma. The combination of asymmetric clinical features, patchy skin manifestations and neoplastic association previously led to the suggestion that this could be a mosaic condition, possibly involving Hedgehog (Hh) signaling. Here we show that CJS is caused by recurrent somatic mosaicism for a nonsynonymous variant in SMO (c.1234C>T; p.Leu412Phe), encoding Smoothened (SMO), a G protein-coupled receptor that transduces Hh signaling. We identified eight mutation-proven individuals (including two previously unreported), with highly similar phenotypes, in whom we demonstrate varying amounts of the mutant allele in different tissues. We present detailed findings from magnetic resonance brain imaging in three mutation-positive cases. Somatic mutations of SMO that result in constitutive activation have been described in several tumors, including medulloblastoma, ameloblastoma and basal cell carcinoma. Strikingly, the most common of these mutations is the identical nonsynonymous variant encoding p.Leu412Phe. Furthermore, this substitution has been shown to activate SMO in the absence of Hh signaling, providing an explanation for tumor development in CJS. This raises therapeutic possibilities using recently generated Hh pathway inhibitors. In summary, our work uncovers the major genetic cause of CJS and illustrates strategies for gene discovery in the context of low-level tissue-specific somatic mosaicism.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/j.ajhg.2016.04.007

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
RDM Clinical Laboratory Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
RDM Clinical Laboratory Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
Weatherall Insti. of Molecular Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
RDM Clinical Laboratory Sciences
Role:
Author


National Institute for Health Research Oxford Biomedical Research Centre More from this funder
Funding agency for:
Taylor, J
Funding agency for:
Wilkie, A
Funding agency for:
Wilkie, A
Grant:
Senior Investigator Award 102731
Grant:
Senior Investigator Award 102731
Wellcome Trust More from this funder
Funding agency for:
Twigg, S
Funding agency for:
Wilkie, A
Funding agency for:
Wilkie, A
Grant:
093329
Grant:
Senior Investigator Award 102731
Grant:
093329; 102731
Grant:
Senior Investigator Award 102731
National Institute for Health Research Oxford Biomedical Research Centre More from this funder


Publisher:
Cell Press
Journal:
American Journal of Human Genetics More from this journal
Volume:
98
Issue:
6
Pages:
1256–1265
Publication date:
2016-01-01
Acceptance date:
2016-04-13
DOI:
EISSN:
1537-6605
ISSN:
0002-9297


Pubs id:
pubs:615401
UUID:
uuid:bd0f6d9c-4c72-4a77-a958-6e0646d0aaaa
Local pid:
pubs:615401
Source identifiers:
615401
Deposit date:
2016-04-15
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP